Pediatrix Medical Group, Inc. Quarterly Interest Expense in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Pediatrix Medical Group, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q2 2024.
  • Pediatrix Medical Group, Inc. Interest Expense for the quarter ending June 30, 2024 was $10.3M, a 8.21% decline year-over-year.
  • Pediatrix Medical Group, Inc. Interest Expense for the twelve months ending June 30, 2024 was $41.4M, a 0.67% increase year-over-year.
  • Pediatrix Medical Group, Inc. annual Interest Expense for 2023 was $42.1M, a 6% increase from 2022.
  • Pediatrix Medical Group, Inc. annual Interest Expense for 2022 was $39.7M, a 42.2% decline from 2021.
  • Pediatrix Medical Group, Inc. annual Interest Expense for 2021 was $68.7M, a 37.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $41.4M $10.3M -$922K -8.21% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $42.3M $10.6M +$209K +2.01% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $42.1M $10.1M +$129K +1.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $41.9M $10.4M +$858K +9.02% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $41.1M $11.2M +$2.82M +33.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $38.3M $10.4M -$1.43M -12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $39.7M $9.95M -$6.65M -40.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $46.3M $9.52M -$8.08M -45.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $54.4M $8.41M -$8.47M -50.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $62.9M $11.8M -$5.83M -33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $68.7M $16.6M -$10.7M -39.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $79.4M $17.6M -$9.66M -35.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $89.1M $16.9M -$11.4M -40.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $100M $17.6M -$10M -36.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $110M $27.3M -$355K -1.28% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 $111M $27.3M -$2.66M -8.89% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $113M $28.3M -$2.75M -8.86% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $116M $27.7M -$2.68M -8.84% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $119M $27.7M +$2.21M +8.68% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 $117M $29.9M +$8.12M +37.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 $109M $31M +$9.4M +43.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 $99.2M $30.3M +$10.4M +52.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $88.8M $25.4M +$5.6M +28.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 $83.2M $21.8M +$3.36M +18.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-20
Q2 2018 $79.8M $21.6M +$3.08M +16.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-20
Q1 2018 $76.7M $19.9M +$2.18M +12.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-20
Q4 2017 $74.6M $19.8M +$3.49M +21.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 $71.1M $18.4M +$1.21M +7.05% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-14
Q2 2017 $69.9M $18.5M +$3.48M +23.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-14
Q1 2017 $66.4M $17.8M +$3.29M +22.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-14
Q4 2016 $63.1M $16.4M +$7.86M +92.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-14
Q3 2016 $55.2M $17.2M +$11M +178% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-14
Q2 2016 $44.2M $15.1M +$9.91M +192% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-14
Q1 2016 $34.3M $14.5M +$11.2M +343% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-14
Q4 2015 $23.1M $8.49M +$5.18M +156% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-10
Q3 2015 $17.9M $6.2M +$4.18M +207% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-10
Q2 2015 $13.7M $5.15M +$2.96M +135% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-10
Q1 2015 $10.8M $3.27M +$1.9M +138% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-10
Q4 2014 $8.89M $3.31M +$2.27M +217% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-11
Q3 2014 $6.62M $2.02M +$512K +34% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-11
Q2 2014 $6.11M $2.19M +$515K +30.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-11
Q1 2014 $5.6M $1.37M +$182K +15.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-11
Q4 2013 $5.42M $1.05M -$173K -14.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-09
Q3 2013 $5.59M $1.51M +$883K +142% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-09
Q2 2013 $4.71M $1.67M +$825K +97.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-09
Q1 2013 $3.88M $1.19M +$635K +115% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-09
Q4 2012 $3.25M $1.22M +$535K +78.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-12
Q3 2012 $2.71M $624K -$432K -40.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-12
Q2 2012 $3.14M $848K -$140K -14.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-12
Q1 2012 $3.28M $554K -$357K -39.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-12
Q4 2011 $3.64M $684K -$200K -22.6% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $3.84M $1.06M +$575K +120% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 $3.26M $988K -$130K -11.6% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 $3.39M $911K +$201K +28.3% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q4 2010 $3.19M $884K Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $481K Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $1.12M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $710K Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.